EVANS; Mark J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for EVANS; Mark J..The latest application filed is for "treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement".

Company Profile

2.10.11

EVANS; Mark J. - Radnor PA
Evans; Mark J. - Silver Spring MD
Evans, Mark J - Radnor PA
Evans; Mark J. - Cheshire CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20200392216 - BELL; Leonard ; et al.	2020-12-17
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 10,703,809 - Bell , et al.	2020-07-07
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20200199211 - BELL; Leonard ; et al.	2020-06-25
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 10,590,189 - Bell , et al.	2020-03-17
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20170349652 - BELL; Leonard ; et al.	2017-12-07
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,732,149 - Bell , et al. August 15, 2	2017-08-15
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,725,504 - Bell , et al. August 8, 2	2017-08-08
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,718,880 - Bell , et al. August 1, 2	2017-08-01
System and method for preservation of digital records Grant 8,087,063 - Martin , et al. December 27, 2	2011-12-27
Systems and methods for establishing authenticity of electronic records in an archives system Grant 7,792,791 - Smolen , et al. September 7, 2	2010-09-07
FXR Agonists for the Treatment of Nonalcoholic Fatty Liver and Cholesterol Gallstone Diseases App 20090163474 - Zhang; Songwen ; et al.	2009-06-25
FXR Agonists for the Treatment of Malignancies App 20080299118 - Hartman; Helen B. ; et al.	2008-12-04
Member of the lysyl oxidase gene family Grant 7,445,920 - Evans , et al. November 4, 2	2008-11-04
Systems and methods for establishing authenticity of electronic records in an archives system App 20070283417 - Smolen; Richard ; et al.	2007-12-06
System and method for preservation of digital records App 20070271258 - Martin; Sean ; et al.	2007-11-22
System and method for managing records through establishing semantic coherence of related digital components including the identification of the digital components using templates App 20070260575 - Robinson; Fred Y. ; et al.	2007-11-08
Member of the lysyl oxidase gene family Grant 7,208,300 - Evans , et al. April 24, 2	2007-04-24
Inhibitors of inflammatory gene activity and cholesterol biosynthesis App 20050221328 - Evans, Mark J ; et al.	2005-10-06
Novel member of the lysyl oxidase gene family App 20040171110 - Evans, Mark J. ; et al.	2004-09-02
Novel member of the lysyl oxidase gene family App 20020102645 - Evans, Mark J. ; et al.	2002-08-01
C5-specific antibodies for the treatment of inflammatory diseases Grant 6,355,245 - Evans , et al. March 12, 2	2002-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.